Clinical trials in Bankya

Clinical trial activity in Bankya is focused on cardiovascular disease and nutritional and metabolic diseases, with studies looking at ways to improve long-term health outcomes in people at higher risk.

• Evaluating a potential therapy for reducing the risk of major heart and blood vessel events
• Studying treatment effects in people with obesity and related metabolic conditions
• Exploring whether new approaches can better support prevention and disease control

This research is aimed at understanding how new treatments may help lower serious cardiovascular risks and improve care for patients with complex metabolic health needs.

Another key area of study involves chronic kidney disease, including cases with or without type 2 diabetes, where researchers are examining whether new therapies can reduce kidney damage and slow disease progression.

• Assessing treatment impact on kidney health through changes linked to urinary albumin levels
• Focusing on patients with chronic kidney disease alongside metabolic risk factors
• Comparing how different treatment strategies may support better renal outcomes

These studies reflect a practical effort to improve diagnosis-related markers and treatment effectiveness in kidney disease management.